Cargando…

Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis

OBJECTIVES: Our objective was to compare the cardiovascular safety of tocilizumab and other biological disease-modifying antirheumatic drugs (bDMARD) in rheumatoid arthritis using a network meta-analysis (NMA). METHODS: A systematic literature search through May 2018 identified randomized controlled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castagné, Benjamin, Viprey, Marie, Martin, Julie, Schott, Anne-Marie, Cucherat, Michel, Soubrier, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675055/ https://www.ncbi.nlm.nih.gov/pubmed/31369575 http://dx.doi.org/10.1371/journal.pone.0220178

Ejemplares similares

Pooling, meta-analysis, and the evaluation of drug safety
por: Lièvre, Michel, et al.
Publicado: (2002)

Quantification and visualisation methods of data-driven chronic care delivery pathways: protocol for a systematic review and content analysis
por: Siqueira do Prado, Luiza, et al.
Publicado: (2020)

Increase of vitamin D assays prescriptions and associated factors: a population-based cohort study
por: Caillet, Pascal, et al.
Publicado: (2017)

GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis
por: Grenet, Guillaume, et al.
Publicado: (2019)

Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
por: Soubrier, Martin, et al.
Publicado: (2016)

Low Osteoporosis Treatment Initiation Rate in Women after Distal Forearm or Proximal Humerus Fracture: A Healthcare Database Nested Cohort Study
por: Viprey, Marie, et al.
Publicado: (2015)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis
por: Luo, Lili, et al.
Publicado: (2022)

Greater Response to Placebo in Children Than in Adults: A Systematic Review and Meta-Analysis in Drug-Resistant Partial Epilepsy
por: Rheims, Sylvain, et al.
Publicado: (2008)

Illness beliefs and emotional responses in mildly disabled stroke survivors: A qualitative study
por: Della Vecchia, Claire, et al.
Publicado: (2019)

Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and meta-analysis of clinical trial studies
por: Saki, Amal, et al.
Publicado: (2021)

Effectiveness and safety of tocilizumab for COVID-19: a systematic review and meta-analysis of randomized clinical trials
por: Almeida, Paula Ribeiro Lopes, et al.
Publicado: (2022)

A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack
por: Viprey, Marie, et al.
Publicado: (2020)

Identification of biopSychoSocial factors predictive of post-traUmatic stress disorder in patients admitted to the Emergency department after a trauma (ISSUE): protocol for a multicenter prospective study
por: Wafa, Mohammad-Hashim, et al.
Publicado: (2019)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
por: Kashour, Tarek, et al.
Publicado: (2021)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis
por: Zeraatkar, Dena, et al.
Publicado: (2022)

Tocilizumab for severe COVID-19: a systematic review and meta-analysis
por: Lan, Shao-Huan, et al.
Publicado: (2020)

Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2021)

Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis
por: Cherian, Jerin Jose, et al.
Publicado: (2022)

Risk of drug use during pregnancy: master protocol for living systematic reviews and meta-analyses performed in the metaPreg project
por: Picot, Cyndie, et al.
Publicado: (2023)

Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
por: Wei, Qiu, et al.
Publicado: (2021)

Re: ‘Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis’ by Tleyjeh et al.
por: Koeckerling, David, et al.
Publicado: (2021)

Prevalence of low health literacy levels in decompensated heart failure compared with acute myocardial infarction patients
por: Perrin, Adèle, et al.
Publicado: (2021)

Adherence with brand versus generic bisphosphonates among osteoporosis patients: a new-user cohort study in the French National Healthcare Insurance database
por: Viprey, Marie, et al.
Publicado: (2020)

Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis
por: Mai, Vicky, et al.
Publicado: (2021)

Integrated safety in tocilizumab clinical trials
por: Schiff, Michael H, et al.
Publicado: (2011)

Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence
por: Kotak, Sohny, et al.
Publicado: (2020)

Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19)
por: Chen, Chong-xiang, et al.
Publicado: (2021)

Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis
por: Kang, Limei, et al.
Publicado: (2023)

Tocilizumab: A Review of Its Safety and Efficacy in Rheumatoid Arthritis
por: Jones, Graeme, et al.
Publicado: (2010)

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
por: Yu, Su-Yeon, et al.
Publicado: (2022)

Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia
por: Klopfenstein, Timothée, et al.
Publicado: (2021)

Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis
por: Mai, Vicky, et al.
Publicado: (2019)

Time for tocilizumab in COVID-19?
por: Butler, Ethan, et al.
Publicado: (2021)

Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis
por: Wei, Qige, et al.
Publicado: (2023)

Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis
por: Giraud, C., et al.
Publicado: (2016)

Symptom-Modifying Effect of Chondroitin Sulfate in Knee Osteoarthritis: A Meta-Analysis of Randomized Placebo-Controlled Trials Performed with Structum(®)
por: Schneider, Heinz, et al.
Publicado: (2012)

Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis
por: Nugroho, Cahyo Wibisono, et al.
Publicado: (2021)

Effectiveness of tocilizumab in the treatment of hospitalized adults COVID-19: A systematic review and meta-analysis
por: Zhang, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qjbbo2vocaivmn1vnl1v5dfao8